Reported Adverse Events (Side Effects) Following COVID-19 Vaccination Among University Students and Staff: A Case of Islamic University in Uganda.

The East African health research journal Pub Date : 2025-01-01 Epub Date: 2025-09-30 DOI:10.24248/eahrj.v9i1.821
Rashid Naziru, Madinah Nabukeera Ssebyala, Francis Tamale, Zakariyah Mukasa, John Turyagumanawe, Alex Daama, Areemu Abdul Mujeeb Babatunde, Swaibu Zziwa, Kharim Mwebaza Muluya
{"title":"Reported Adverse Events (Side Effects) Following COVID-19 Vaccination Among University Students and Staff: A Case of Islamic University in Uganda.","authors":"Rashid Naziru, Madinah Nabukeera Ssebyala, Francis Tamale, Zakariyah Mukasa, John Turyagumanawe, Alex Daama, Areemu Abdul Mujeeb Babatunde, Swaibu Zziwa, Kharim Mwebaza Muluya","doi":"10.24248/eahrj.v9i1.821","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Since its outbreak, COVID-19 has brought several disastrous effects on the healthcare and economic systems of different countries globally. There is still no approved curative medicine for COVID-19; thus, the disease can only be controlled through preventive measures, especially vaccination through herd immunity. However, this is still far from being realized, as vaccination is still being affected by hesitancy and resistance from people, mainly due to the fears of side effects and other adverse events following vaccination. Therefore, understanding the incidence and associated factors, nature, and management of these adverse events is paramount for ensuring public confidence in vaccination programmes. The current study therefore aimed at documenting reported adverse events following COVID-19 vaccination among students and staff at the Islamic university in Uganda.</p><p><strong>Methodology: </strong>This was a cross-sectional study design that was prospective in nature that recruited staff and students from Islamic University in Uganda that received COVID-19 vaccination between February and June 2022. Data was collected using Google Forms; participants were reached through the institutional ERP, emails, text messages and WhatsApp (social media). Data analysis was done using SPSS version 20.</p><p><strong>Results: </strong>The study recruited 225 participants; 64.0% were female, and the median age range was between 26 and 30 years. Most of the respondents, 76.4%, reported receiving at least one side effect. More than 73% did not report any comorbidity (chronic conditions). 70.5% had received two doses of COVID-19 vaccines, and AstraZeneca was the most received brand at 51.8%. Most participants reported minor side effects, including pain at the injection site (44.4%). fever, chills, headache, and dizziness at 18.1%, and muscle pains and backpains at 14.6%. Only 1.2% reported vaccine sexual reproductive health.</p><p><strong>Conclusions and recommendation: </strong>The study confirms that COVID-19 vaccines are safe, as most of the reported side effects were minor with no life-threatening events. More sensitization of the community about the safety of vaccines is encouraged. Ongoing pharmacovigilance surveys for COVID-19 vaccines are recommended to detect possible long-term side effects.</p>","PeriodicalId":74991,"journal":{"name":"The East African health research journal","volume":"9 1","pages":"41-47"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12591008/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The East African health research journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24248/eahrj.v9i1.821","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Since its outbreak, COVID-19 has brought several disastrous effects on the healthcare and economic systems of different countries globally. There is still no approved curative medicine for COVID-19; thus, the disease can only be controlled through preventive measures, especially vaccination through herd immunity. However, this is still far from being realized, as vaccination is still being affected by hesitancy and resistance from people, mainly due to the fears of side effects and other adverse events following vaccination. Therefore, understanding the incidence and associated factors, nature, and management of these adverse events is paramount for ensuring public confidence in vaccination programmes. The current study therefore aimed at documenting reported adverse events following COVID-19 vaccination among students and staff at the Islamic university in Uganda.

Methodology: This was a cross-sectional study design that was prospective in nature that recruited staff and students from Islamic University in Uganda that received COVID-19 vaccination between February and June 2022. Data was collected using Google Forms; participants were reached through the institutional ERP, emails, text messages and WhatsApp (social media). Data analysis was done using SPSS version 20.

Results: The study recruited 225 participants; 64.0% were female, and the median age range was between 26 and 30 years. Most of the respondents, 76.4%, reported receiving at least one side effect. More than 73% did not report any comorbidity (chronic conditions). 70.5% had received two doses of COVID-19 vaccines, and AstraZeneca was the most received brand at 51.8%. Most participants reported minor side effects, including pain at the injection site (44.4%). fever, chills, headache, and dizziness at 18.1%, and muscle pains and backpains at 14.6%. Only 1.2% reported vaccine sexual reproductive health.

Conclusions and recommendation: The study confirms that COVID-19 vaccines are safe, as most of the reported side effects were minor with no life-threatening events. More sensitization of the community about the safety of vaccines is encouraged. Ongoing pharmacovigilance surveys for COVID-19 vaccines are recommended to detect possible long-term side effects.

Abstract Image

大学生和工作人员接种COVID-19疫苗后报告的不良事件(副作用):乌干达伊斯兰大学一例
背景:自疫情爆发以来,COVID-19给全球不同国家的医疗保健和经济体系带来了若干灾难性影响。目前仍没有批准的治疗COVID-19的药物;因此,这种疾病只能通过预防措施加以控制,特别是通过群体免疫接种疫苗。然而,这还远远没有实现,因为疫苗接种仍然受到人们的犹豫和抵制的影响,这主要是由于担心疫苗接种后的副作用和其他不良事件。因此,了解这些不良事件的发生率和相关因素、性质和管理对于确保公众对疫苗接种规划的信心至关重要。因此,目前的研究旨在记录乌干达伊斯兰大学的学生和工作人员在接种COVID-19疫苗后报告的不良事件。方法:这是一项前瞻性横断面研究设计,招募了乌干达伊斯兰大学的工作人员和学生,他们在2022年2月至6月期间接种了COVID-19疫苗。使用谷歌表格收集数据;通过机构ERP、电子邮件、短信和WhatsApp(社交媒体)联系到参与者。数据分析使用SPSS version 20。结果:该研究招募了225名参与者;女性占64.0%,年龄中位数在26 - 30岁之间。大多数受访者(76.4%)报告至少有一种副作用。超过73%的患者未报告任何合并症(慢性疾病)。70.5%的人接种了两剂新冠病毒疫苗,阿斯利康(AstraZeneca)是接种率最高的品牌,占51.8%。大多数参与者报告了轻微的副作用,包括注射部位疼痛(44.4%)。发烧、寒战、头痛和头晕占18.1%,肌肉疼痛和背痛占14.6%。只有1.2%的人报告了疫苗性生殖健康。结论和建议:该研究证实COVID-19疫苗是安全的,因为大多数报告的副作用很小,没有危及生命的事件。鼓励加强社区对疫苗安全性的认识。建议对COVID-19疫苗进行持续的药物警戒调查,以发现可能的长期副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书